WuXi Biologics (Cayman) Inc. ADR (1FW1)
FSX
11.30
+0.70 (+6.60%)
Closed
Aug 25, 2026
Day's Range
11.1011.30
52 wk Range
6.3011.30
Financial Statements - 1FW1 - WuXi Biologics (Cayman) Inc. ADR
Revenue
21.79B▲ 16.7%
Net Income
5.73B▲ 45.3%Net Margin 26.3%
EBITDA
8.48B▲ 28.8%
Free Cash Flow
2.60B▲ 102.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 21.79B | 18.67B | 17.03B | 15.26B | 10.29B | 5.61B |
| Cost of Goods | 11.77B | 11.02B | 10.20B | 8.54B | 5.46B | 3.07B |
| Gross Profit | 10.01B | 7.65B | 6.82B | 6.72B | 4.82B | 2.53B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 7.05B | 4.97B | 4.45B | 4.79B | 3.46B | 1.76B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 7.25B | 4.83B | 4.17B | 5.35B | 3.99B | 1.96B |
| Income Tax | 1.52B | 889.02M | 603.17M | 807.86M | 484.53M | 273.06M |
| Net Income | 5.73B | 3.94B | 3.57B | 4.54B | 3.50B | 1.69B |
| EPS Basic | 2.44 | 1.64 | 1.64 | 2.12 | 1.62 | 0.86 |
| EPS Diluted | 2.32 | 1.56 | 1.54 | 2.02 | 1.54 | 0.8 |
| Basic Shares Outstanding | 2.01B | 2.04B | 2.08B | 2.08B | 17.18B | 16.27B |
| Diluted Shares Outstanding | 2.01B | 2.04B | 2.08B | 2.08B | 17.18B | 16.27B |
| Ebit | 7.39B | 4.99B | 4.33B | 5.42B | 4.03B | 2B |
| Ebitda | 8.48B | 6.59B | 5.70B | 6.95B | 4.33B | 2.06B |
| Net Income Continuous Operations | 7.25B | 4.83B | 4.17B | 5.35B | 3.99B | 1.96B |
| Minority Interests | -824.88M | -589.29M | -170.89M | -129.62M | -120.10M | -3.80M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
